| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | EPHB2 PHKA2 STK10 BMPR2 EPHA6 ERN1 CAMK2D STK26 GRK5 PAK5 SCYL1 PAK3 PAK6 EPHA7 | 4.03e-07 | 600 | 89 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.54e-06 | 182 | 89 | 8 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.67e-06 | 184 | 89 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB2 PHKA2 STK10 BMPR2 EPHA6 ERN1 CAMK2D STK26 GRK5 PAK5 SCYL1 PAK3 PAK6 EPHA7 | 2.89e-06 | 709 | 89 | 14 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | EPHB2 PHKA2 STK10 BMPR2 EPHA6 ERN1 CAMK2D STK26 GRK5 PAK5 SCYL1 PAK3 PAK6 EPHA7 | 6.82e-06 | 764 | 89 | 14 | GO:0016301 |
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 1.96e-05 | 2 | 89 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 1.96e-05 | 2 | 89 | 2 | GO:0103002 | |
| GeneOntologyMolecularFunction | protein dimerization activity | TYR STK10 KLHL2 PTPA EPM2A GLA ERN1 CAMK2D STK26 LPL LRP6 GABBR2 G6PD EPAS1 GABBR1 TP53BP2 NPAS1 | 2.02e-05 | 1205 | 89 | 17 | GO:0046983 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 2.94e-05 | 446 | 89 | 10 | GO:0004674 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 3.75e-05 | 15 | 89 | 3 | GO:0005005 | |
| GeneOntologyMolecularFunction | G protein-coupled GABA receptor activity | 5.88e-05 | 3 | 89 | 2 | GO:0004965 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | TYR STK10 KLHL2 PTPA EPM2A GLA ERN1 CAMK2D STK26 LPL LRP6 G6PD TP53BP2 | 6.34e-05 | 815 | 89 | 13 | GO:0042803 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB2 PHKA2 STK10 BMPR2 EPHA6 ERN1 CAMK2D STK26 GRK5 PAK5 SCYL1 PAK3 PAK6 EPHA7 | 6.60e-05 | 938 | 89 | 14 | GO:0016772 |
| GeneOntologyMolecularFunction | ephrin receptor activity | 7.88e-05 | 19 | 89 | 3 | GO:0005003 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.23e-04 | 334 | 89 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.07e-04 | 26 | 89 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 4.07e-04 | 7 | 89 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 4.07e-04 | 7 | 89 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 5.67e-04 | 85 | 89 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 8.57e-04 | 343 | 89 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 8.64e-04 | 10 | 89 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 8.64e-04 | 10 | 89 | 2 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 8.64e-04 | 10 | 89 | 2 | GO:0102033 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.02e-03 | 459 | 89 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.19e-03 | 363 | 89 | 7 | GO:0106310 | |
| GeneOntologyMolecularFunction | FK506 binding | 1.26e-03 | 12 | 89 | 2 | GO:0005528 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.44e-03 | 50 | 89 | 3 | GO:0003755 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.48e-03 | 13 | 89 | 2 | GO:0008046 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.48e-03 | 13 | 89 | 2 | GO:0016713 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.62e-03 | 52 | 89 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.71e-03 | 53 | 89 | 3 | GO:0016859 | |
| GeneOntologyMolecularFunction | macrolide binding | 1.73e-03 | 14 | 89 | 2 | GO:0005527 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.73e-03 | 14 | 89 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.73e-03 | 14 | 89 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | arachidonate binding | 1.99e-03 | 15 | 89 | 2 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 2.26e-03 | 16 | 89 | 2 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 2.26e-03 | 16 | 89 | 2 | GO:0050543 | |
| GeneOntologyMolecularFunction | channel activity | 2.37e-03 | 525 | 89 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.40e-03 | 526 | 89 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.56e-03 | 17 | 89 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.87e-03 | 18 | 89 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | steroid binding | 2.97e-03 | 133 | 89 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 3.06e-03 | 65 | 89 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 3.54e-03 | 20 | 89 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | ceramide binding | 3.54e-03 | 20 | 89 | 2 | GO:0097001 | |
| GeneOntologyMolecularFunction | sterol binding | 3.93e-03 | 71 | 89 | 3 | GO:0032934 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 4.04e-03 | 145 | 89 | 4 | GO:0004713 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 4.28e-03 | 22 | 89 | 2 | GO:0016917 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.74e-03 | 465 | 89 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 4.78e-03 | 152 | 89 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 5.09e-03 | 24 | 89 | 2 | GO:0008392 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 5.96e-03 | 26 | 89 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 6.41e-03 | 27 | 89 | 2 | GO:0004683 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 6.41e-03 | 27 | 89 | 2 | GO:0008391 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 6.89e-03 | 28 | 89 | 2 | GO:0036041 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 6.89e-03 | 28 | 89 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 6.89e-03 | 28 | 89 | 2 | GO:0000030 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1F PTPA TMEM249 SCN1A SCN2A KCNK5 CACNA1H ATP5MJ GRIN2C KCNG3 | 5.25e-06 | 378 | 90 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | cation channel complex | 7.94e-06 | 235 | 90 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | G protein-coupled GABA receptor complex | 1.83e-05 | 2 | 90 | 2 | GO:1902712 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.60e-05 | 277 | 90 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 5.02e-05 | 17 | 90 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | G protein-coupled receptor heterodimeric complex | 5.48e-05 | 3 | 90 | 2 | GO:0038039 | |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1F PTPA ERN1 TMEM249 SCN1A SCN2A SOCS4 SCYL1 KCNK5 LRP6 CACNA1H ATP5MJ GRIN2C DENND5A GABBR2 KCNG3 GABBR1 VDAC1 | 5.95e-05 | 1498 | 90 | 18 | GO:0098796 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1F PTPA TMEM249 SCN1A SCN2A KCNK5 CACNA1H ATP5MJ GRIN2C KCNG3 | 8.40e-05 | 523 | 90 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | CACNA1F PTPA TMEM249 SCN1A SCN2A KCNK5 CACNA1H ATP5MJ GRIN2C KCNG3 | 1.27e-04 | 550 | 90 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | synaptic membrane | EPHB2 SCN1A SCN2A NTNG1 CACNA1H GRIN2C GABBR2 GABBR1 VDAC1 EPHA7 | 2.04e-04 | 583 | 90 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | axon initial segment | 2.60e-04 | 29 | 90 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.60e-04 | 29 | 90 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.79e-04 | 73 | 90 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | G protein-coupled receptor dimeric complex | 3.80e-04 | 7 | 90 | 2 | GO:0038037 | |
| GeneOntologyCellularComponent | postsynapse | EPHB2 BMPR2 GPR50 CAMK2D CASKIN1 PAK3 CACNA1H GRIN2C PAK6 GABBR2 GABBR1 VDAC1 EPHA7 | 4.05e-04 | 1018 | 90 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | main axon | 5.93e-04 | 89 | 90 | 4 | GO:0044304 | |
| GeneOntologyCellularComponent | neuronal cell body | EPHB2 CACNA1F BMPR2 EPM2A CAMK2D SCN1A CASP6 LRP6 CACNA1H GABBR1 EPHA7 | 9.06e-04 | 835 | 90 | 11 | GO:0043025 |
| GeneOntologyCellularComponent | G protein-coupled receptor complex | 9.83e-04 | 11 | 90 | 2 | GO:0097648 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.02e-03 | 46 | 90 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.83e-03 | 405 | 90 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.87e-03 | 523 | 90 | 8 | GO:0098984 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1F TMEM249 SCN1A SCN2A LRP6 CACNA1H GRIN2C GABBR2 KCNG3 GABBR1 | 2.00e-03 | 785 | 90 | 10 | GO:0098797 |
| GeneOntologyCellularComponent | cell body | EPHB2 CACNA1F BMPR2 EPM2A CAMK2D SCN1A CASP6 LRP6 CACNA1H GABBR1 EPHA7 | 2.12e-03 | 929 | 90 | 11 | GO:0044297 |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 CACNA1F BMPR2 EPM2A EPHA6 CAMK2D SCN1A CASP6 LRP6 CACNA1H OSBP2 GABBR1 EPHA7 | 2.25e-03 | 1228 | 90 | 13 | GO:0036477 |
| GeneOntologyCellularComponent | glutamatergic synapse | EPHB2 CASKIN1 SCN2A NTNG1 PAK3 CACNA1H GRIN2C GABBR2 GABBR1 EPHA7 | 2.68e-03 | 817 | 90 | 10 | GO:0098978 |
| GeneOntologyCellularComponent | intercalated disc | 3.16e-03 | 68 | 90 | 3 | GO:0014704 | |
| GeneOntologyCellularComponent | node of Ranvier | 3.31e-03 | 20 | 90 | 2 | GO:0033268 | |
| GeneOntologyCellularComponent | postsynaptic density | 3.33e-03 | 451 | 90 | 7 | GO:0014069 | |
| GeneOntologyCellularComponent | GABA receptor complex | 3.65e-03 | 21 | 90 | 2 | GO:1902710 | |
| GeneOntologyCellularComponent | cytoplasmic side of endoplasmic reticulum membrane | 4.00e-03 | 22 | 90 | 2 | GO:0098554 | |
| GeneOntologyCellularComponent | asymmetric synapse | 4.52e-03 | 477 | 90 | 7 | GO:0032279 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 4.65e-03 | 78 | 90 | 3 | GO:0048787 | |
| GeneOntologyCellularComponent | T-tubule | 4.82e-03 | 79 | 90 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 5.16e-03 | 25 | 90 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 6.01e-03 | 503 | 90 | 7 | GO:0099572 | |
| MousePheno | abnormal vascular resistance | 2.94e-06 | 19 | 76 | 4 | MP:0005532 | |
| MousePheno | clonic seizures | 5.38e-05 | 14 | 76 | 3 | MP:0003996 | |
| MousePheno | abnormal long-term spatial reference memory | 7.01e-05 | 41 | 76 | 4 | MP:0008432 | |
| Domain | Prot_kinase_dom | EPHB2 STK10 BMPR2 EPHA6 ERN1 CAMK2D STK26 GRK5 PAK5 SCYL1 PAK3 PAK6 EPHA7 | 6.07e-07 | 489 | 90 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | EPHB2 STK10 BMPR2 EPHA6 ERN1 CAMK2D STK26 GRK5 PAK5 SCYL1 PAK3 PAK6 EPHA7 | 6.65e-07 | 493 | 90 | 13 | PS50011 |
| Domain | Kinase-like_dom | EPHB2 STK10 BMPR2 EPHA6 ERN1 CAMK2D STK26 GRK5 PAK5 SCYL1 PAK3 PAK6 EPHA7 | 1.91e-06 | 542 | 90 | 13 | IPR011009 |
| Domain | PROTEIN_KINASE_ATP | EPHB2 STK10 BMPR2 EPHA6 ERN1 CAMK2D STK26 GRK5 PAK5 PAK3 PAK6 EPHA7 | 2.03e-06 | 459 | 90 | 12 | PS00107 |
| Domain | Protein_kinase_ATP_BS | EPHB2 STK10 BMPR2 EPHA6 CAMK2D STK26 GRK5 PAK5 PAK3 PAK6 EPHA7 | 2.06e-06 | 379 | 90 | 11 | IPR017441 |
| Domain | Channel_four-helix_dom | 7.98e-06 | 57 | 90 | 5 | IPR027359 | |
| Domain | - | 7.98e-06 | 57 | 90 | 5 | 1.20.120.350 | |
| Domain | Pkinase | 1.49e-05 | 381 | 90 | 10 | PF00069 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 3.79e-05 | 14 | 90 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 3.79e-05 | 14 | 90 | 3 | PS00790 | |
| Domain | Eph_TM | 3.79e-05 | 14 | 90 | 3 | IPR027936 | |
| Domain | Tyr_kinase_rcpt_V_CS | 3.79e-05 | 14 | 90 | 3 | IPR001426 | |
| Domain | EPH_lbd | 3.79e-05 | 14 | 90 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 3.79e-05 | 14 | 90 | 3 | PF01404 | |
| Domain | EphA2_TM | 3.79e-05 | 14 | 90 | 3 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 3.79e-05 | 14 | 90 | 3 | IPR016257 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 3.79e-05 | 14 | 90 | 3 | IPR001090 | |
| Domain | EPH_LBD | 3.79e-05 | 14 | 90 | 3 | PS51550 | |
| Domain | PBD | 5.79e-05 | 16 | 90 | 3 | SM00285 | |
| Domain | PROTEIN_KINASE_ST | 6.20e-05 | 362 | 90 | 9 | PS00108 | |
| Domain | GPCR3_GABA-B | 6.87e-05 | 3 | 90 | 2 | IPR002455 | |
| Domain | PBD | 7.01e-05 | 17 | 90 | 3 | PF00786 | |
| Domain | CRIB | 1.16e-04 | 20 | 90 | 3 | PS50108 | |
| Domain | CRIB_dom | 1.35e-04 | 21 | 90 | 3 | IPR000095 | |
| Domain | Ion_trans_dom | 2.26e-04 | 114 | 90 | 5 | IPR005821 | |
| Domain | Ion_trans | 2.26e-04 | 114 | 90 | 5 | PF00520 | |
| Domain | DOCK_N | 2.27e-04 | 5 | 90 | 2 | PF16172 | |
| Domain | DOCK_N | 2.27e-04 | 5 | 90 | 2 | IPR032376 | |
| Domain | Ephrin_rec_like | 2.30e-04 | 25 | 90 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 2.30e-04 | 25 | 90 | 3 | IPR011641 | |
| Domain | SAM_1 | 3.24e-04 | 68 | 90 | 4 | PF00536 | |
| Domain | Ser/Thr_kinase_AS | 3.27e-04 | 357 | 90 | 8 | IPR008271 | |
| Domain | S_TKc | 3.39e-04 | 359 | 90 | 8 | SM00220 | |
| Domain | Na_trans_cytopl | 3.40e-04 | 6 | 90 | 2 | PF11933 | |
| Domain | PAK_BD | 3.40e-04 | 6 | 90 | 2 | IPR033923 | |
| Domain | Na_trans_cytopl | 3.40e-04 | 6 | 90 | 2 | IPR024583 | |
| Domain | - | 4.26e-04 | 73 | 90 | 4 | 2.60.120.260 | |
| Domain | WASP_C | 4.75e-04 | 7 | 90 | 2 | IPR011026 | |
| Domain | SH3 | 6.20e-04 | 216 | 90 | 6 | SM00326 | |
| Domain | SH3 | 6.20e-04 | 216 | 90 | 6 | PS50002 | |
| Domain | DHC_N1 | 6.31e-04 | 8 | 90 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 6.31e-04 | 8 | 90 | 2 | IPR013594 | |
| Domain | SH3_domain | 6.82e-04 | 220 | 90 | 6 | IPR001452 | |
| Domain | ANF_lig-bd_rcpt | 7.47e-04 | 37 | 90 | 3 | IPR001828 | |
| Domain | ANF_receptor | 7.47e-04 | 37 | 90 | 3 | PF01094 | |
| Domain | SAM | 8.63e-04 | 88 | 90 | 4 | SM00454 | |
| Domain | Peripla_BP_I | 8.72e-04 | 39 | 90 | 3 | IPR028082 | |
| Domain | Na_channel_asu | 1.01e-03 | 10 | 90 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.01e-03 | 10 | 90 | 2 | IPR010526 | |
| Domain | VDCCAlpha1 | 1.01e-03 | 10 | 90 | 2 | IPR002077 | |
| Domain | Na_trans_assoc | 1.01e-03 | 10 | 90 | 2 | PF06512 | |
| Domain | Galactose-bd-like | 1.10e-03 | 94 | 90 | 4 | IPR008979 | |
| Domain | SAM_DOMAIN | 1.15e-03 | 95 | 90 | 4 | PS50105 | |
| Domain | Ephrin_rec_like | 1.23e-03 | 11 | 90 | 2 | PF07699 | |
| Domain | DOCK_C | 1.23e-03 | 11 | 90 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 1.23e-03 | 11 | 90 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.23e-03 | 11 | 90 | 2 | PS51651 | |
| Domain | DHR_1 | 1.23e-03 | 11 | 90 | 2 | PS51650 | |
| Domain | DOCK-C2 | 1.23e-03 | 11 | 90 | 2 | PF14429 | |
| Domain | DHR-2 | 1.23e-03 | 11 | 90 | 2 | IPR027357 | |
| Domain | DHR-2 | 1.23e-03 | 11 | 90 | 2 | PF06920 | |
| Domain | DOCK | 1.23e-03 | 11 | 90 | 2 | IPR026791 | |
| Domain | SAM | 1.24e-03 | 97 | 90 | 4 | IPR001660 | |
| Domain | - | 1.47e-03 | 12 | 90 | 2 | 3.90.810.10 | |
| Domain | Oxysterol-bd | 1.47e-03 | 12 | 90 | 2 | IPR000648 | |
| Domain | Oxysterol-bd_CS | 1.47e-03 | 12 | 90 | 2 | IPR018494 | |
| Domain | Oxysterol_BP | 1.47e-03 | 12 | 90 | 2 | PF01237 | |
| Domain | OSBP | 1.47e-03 | 12 | 90 | 2 | PS01013 | |
| Domain | - | 1.72e-03 | 106 | 90 | 4 | 1.10.150.50 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.01e-03 | 14 | 90 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.01e-03 | 14 | 90 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.01e-03 | 14 | 90 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.01e-03 | 14 | 90 | 2 | PF08393 | |
| Domain | MT | 2.01e-03 | 14 | 90 | 2 | PF12777 | |
| Domain | AAA_8 | 2.01e-03 | 14 | 90 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.01e-03 | 14 | 90 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.01e-03 | 14 | 90 | 2 | PF07728 | |
| Domain | DHC_fam | 2.31e-03 | 15 | 90 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.31e-03 | 15 | 90 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.31e-03 | 15 | 90 | 2 | PF03028 | |
| Domain | SAM/pointed | 2.47e-03 | 117 | 90 | 4 | IPR013761 | |
| Domain | FKBP_PPIASE | 2.64e-03 | 16 | 90 | 2 | PS50059 | |
| Domain | FKBP_C | 2.64e-03 | 16 | 90 | 2 | PF00254 | |
| Domain | PPIase_FKBP | 2.98e-03 | 17 | 90 | 2 | IPR023566 | |
| Domain | PPIase_FKBP_dom | 4.12e-03 | 20 | 90 | 2 | IPR001179 | |
| Domain | PLAT | 4.54e-03 | 21 | 90 | 2 | PS50095 | |
| Domain | - | 4.54e-03 | 21 | 90 | 2 | 2.60.60.20 | |
| Domain | PLAT | 4.54e-03 | 21 | 90 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 4.54e-03 | 21 | 90 | 2 | IPR001024 | |
| Pathway | KEGG_AXON_GUIDANCE | 5.40e-06 | 129 | 75 | 7 | M5539 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1 | 3.98e-05 | 13 | 75 | 3 | M6322 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 5.84e-05 | 40 | 75 | 4 | M39798 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 7.79e-05 | 43 | 75 | 4 | M39788 | |
| Pathway | SIG_CHEMOTAXIS | 9.33e-05 | 45 | 75 | 4 | M5193 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.80e-04 | 21 | 75 | 3 | M27137 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 2.37e-04 | 23 | 75 | 3 | M47666 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.70e-04 | 59 | 75 | 4 | M27140 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 3.06e-04 | 25 | 75 | 3 | MM14858 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 3.07e-04 | 61 | 75 | 4 | MM14861 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.65e-04 | 178 | 75 | 6 | M2890 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 3.91e-04 | 65 | 75 | 4 | MM14911 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 4.40e-04 | 67 | 75 | 4 | M295 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 5.20e-04 | 70 | 75 | 4 | M13266 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 5.84e-04 | 31 | 75 | 3 | M39851 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 6.42e-04 | 74 | 75 | 4 | M48080 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 6.42e-04 | 74 | 75 | 4 | MM15962 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 6.42e-04 | 32 | 75 | 3 | M27455 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 7.04e-04 | 33 | 75 | 3 | MM15918 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 7.69e-04 | 34 | 75 | 3 | MM15025 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 8.38e-04 | 35 | 75 | 3 | M16801 | |
| Pathway | REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA | 9.81e-04 | 9 | 75 | 2 | M26946 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 9.81e-04 | 9 | 75 | 2 | M39819 | |
| Pubmed | Comparison of the physical and recombination maps of the mouse X chromosome. | 5.82e-07 | 7 | 90 | 3 | 2571569 | |
| Pubmed | Efficient linkage of 10 loci in the proximal region of the mouse X chromosome. | 5.82e-07 | 7 | 90 | 3 | 2110546 | |
| Pubmed | 9.30e-07 | 8 | 90 | 3 | 3416629 | ||
| Pubmed | 1.15e-06 | 407 | 90 | 9 | 15772651 | ||
| Pubmed | 1.39e-06 | 9 | 90 | 3 | 2906327 | ||
| Pubmed | 1.98e-06 | 10 | 90 | 3 | 1964443 | ||
| Pubmed | HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia. | 1.98e-06 | 10 | 90 | 3 | 17304517 | |
| Pubmed | 2.72e-06 | 11 | 90 | 3 | 22065784 | ||
| Pubmed | 3.62e-06 | 12 | 90 | 3 | 2899541 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | FKBP10 ABCC1 GLA CAMK2D STK26 DNAH2 SCYL1 LPGAT1 LRP6 ALG1 VDAC1 CDC23 | 5.73e-06 | 942 | 90 | 12 | 31073040 |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 15611369 | ||
| Pubmed | Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits. | 6.62e-06 | 2 | 90 | 2 | 15706241 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 6.62e-06 | 2 | 90 | 2 | 10827969 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 14978362 | ||
| Pubmed | Functional expression of the GABAB receptor in human airway smooth muscle. | 6.62e-06 | 2 | 90 | 2 | 16829628 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19694741 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 15757645 | ||
| Pubmed | Expression of GABA(B) receptors is altered in brains of subjects with autism. | 6.62e-06 | 2 | 90 | 2 | 19002745 | |
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 6.62e-06 | 2 | 90 | 2 | 1317301 | |
| Pubmed | Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. | 6.62e-06 | 2 | 90 | 2 | 23641057 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 31439038 | ||
| Pubmed | Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. | 6.62e-06 | 2 | 90 | 2 | 15240800 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 28912346 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19763258 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 24413902 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 25339677 | ||
| Pubmed | Heterodimerization is required for the formation of a functional GABA(B) receptor. | 6.62e-06 | 2 | 90 | 2 | 9872316 | |
| Pubmed | GABA(B)-receptor subtypes assemble into functional heteromeric complexes. | 6.62e-06 | 2 | 90 | 2 | 9872317 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 21828041 | ||
| Pubmed | [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers]. | 6.62e-06 | 2 | 90 | 2 | 22169642 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 8031839 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 6.62e-06 | 2 | 90 | 2 | 15249644 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 32286880 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 10860550 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20034025 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 10773016 | ||
| Pubmed | Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. | 6.62e-06 | 2 | 90 | 2 | 11320253 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17144904 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 10328880 | ||
| Pubmed | Characterization of the CYP4A11 gene, a second CYP4A gene in humans. | 6.62e-06 | 2 | 90 | 2 | 12464262 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 26595804 | ||
| Pubmed | Structural Basis for Activation of the Heterodimeric GABAB Receptor. | 6.62e-06 | 2 | 90 | 2 | 33058878 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20962240 | ||
| Pubmed | Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin-1beta. | 6.62e-06 | 2 | 90 | 2 | 15066132 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 30693367 | ||
| Pubmed | Profiling of GABAA and GABAB receptor expression in the myometrium of the human uterus. | 6.62e-06 | 2 | 90 | 2 | 30343129 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 29649454 | ||
| Pubmed | Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study. | 6.62e-06 | 2 | 90 | 2 | 21303731 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 32581365 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 23825080 | ||
| Pubmed | Structure and functional interaction of the extracellular domain of human GABA(B) receptor GBR2. | 6.62e-06 | 2 | 90 | 2 | 22660477 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 16691295 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 3829886 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 15305362 | ||
| Pubmed | Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity. | 6.62e-06 | 2 | 90 | 2 | 10075644 | |
| Pubmed | Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice. | 6.62e-06 | 2 | 90 | 2 | 29277328 | |
| Pubmed | Structural basis of the activation of a metabotropic GABA receptor. | 6.62e-06 | 2 | 90 | 2 | 32555460 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 22579910 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 21820496 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 33096315 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 32580208 | ||
| Pubmed | GABAB receptors in Schwann cells influence proliferation and myelin protein expression. | 6.62e-06 | 2 | 90 | 2 | 15147298 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 15304491 | ||
| Pubmed | Renal function and vasomotor activity in mice lacking the Cyp4a14 gene. | 6.62e-06 | 2 | 90 | 2 | 20943934 | |
| Pubmed | The Sushi domains of GABAB receptors function as axonal targeting signals. | 6.62e-06 | 2 | 90 | 2 | 20107064 | |
| Pubmed | Heterodimeric coiled-coil interactions of human GABAB receptor. | 6.62e-06 | 2 | 90 | 2 | 24778228 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 24682435 | ||
| Pubmed | Apoptosis stimulating protein of p53 (ASPP) 1 and ASPP2 m-RNA expression in oral cancer. | 6.62e-06 | 2 | 90 | 2 | 32987288 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 2766933 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 26311622 | ||
| Pubmed | Structural mechanism of ligand activation in human GABA(B) receptor. | 6.62e-06 | 2 | 90 | 2 | 24305054 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 28118741 | ||
| Pubmed | A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency. | 6.62e-06 | 2 | 90 | 2 | 22307442 | |
| Pubmed | [Methylation of phenols using metal-salt catalysts (author's transl)]. | 6.62e-06 | 2 | 90 | 2 | 987231 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 14625043 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 18665320 | ||
| Pubmed | ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells. | 6.62e-06 | 2 | 90 | 2 | 23392125 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 21377452 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17112342 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 21160134 | ||
| Pubmed | High-fat diet-induced obesity and insulin resistance in CYP4a14-/- mice is mediated by 20-HETE. | 6.62e-06 | 2 | 90 | 2 | 30088983 | |
| Pubmed | Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. | 6.62e-06 | 2 | 90 | 2 | 19208908 | |
| Pubmed | 9.16e-06 | 16 | 90 | 3 | 8755474 | ||
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 1.11e-05 | 17 | 90 | 3 | 12217323 | |
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 1.58e-05 | 19 | 90 | 3 | 12684176 | |
| Pubmed | Functional deficits in PAK5, PAK6 and PAK5/PAK6 knockout mice. | 1.98e-05 | 3 | 90 | 2 | 23593460 | |
| Pubmed | Prognostic significance of PAK family kinases in acute myeloid leukemia. | 1.98e-05 | 3 | 90 | 2 | 30890765 | |
| Pubmed | G Protein-coupled receptor kinases phosphorylate LRP6 in the Wnt pathway. | 1.98e-05 | 3 | 90 | 2 | 19801552 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 32185219 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 26817839 | ||
| Pubmed | Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice. | 1.98e-05 | 3 | 90 | 2 | 2354437 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 32005694 | ||
| Pubmed | ASPP: a new family of oncogenes and tumour suppressor genes. | 1.98e-05 | 3 | 90 | 2 | 17211478 | |
| Pubmed | Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR. | 1.98e-05 | 3 | 90 | 2 | 15660124 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 23859570 | ||
| Pubmed | Puerarin alleviates noise-induced hearing loss via affecting PKCγ and GABAB receptor expression. | 1.98e-05 | 3 | 90 | 2 | 25592416 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 16081421 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 23710594 | ||
| Pubmed | Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis. | 1.98e-05 | 3 | 90 | 2 | 28270609 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 17591780 | ||
| Cytoband | 8q24.12 | 2.92e-04 | 13 | 90 | 2 | 8q24.12 | |
| Cytoband | 2q24.3 | 4.48e-04 | 16 | 90 | 2 | 2q24.3 | |
| GeneFamily | Gamma-aminobutyric acid type B receptor subunits|Sushi domain containing | 1.35e-05 | 2 | 67 | 2 | 280 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.72e-05 | 14 | 67 | 3 | 1095 | |
| GeneFamily | Sterile alpha motif domain containing | 3.18e-04 | 88 | 67 | 4 | 760 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.79e-04 | 9 | 67 | 2 | 1203 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 8.72e-04 | 12 | 67 | 2 | 670 | |
| GeneFamily | Dyneins, axonemal | 1.77e-03 | 17 | 67 | 2 | 536 | |
| GeneFamily | FKBP prolyl isomerases | 1.99e-03 | 18 | 67 | 2 | 910 | |
| GeneFamily | Ankyrin repeat domain containing | 2.03e-03 | 242 | 67 | 5 | 403 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.15e-03 | 26 | 67 | 2 | 253 | |
| GeneFamily | Cytochrome P450 family 4 | 7.86e-03 | 36 | 67 | 2 | 1003 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 8.94e-03 | 115 | 67 | 3 | 769 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN | 5.50e-06 | 200 | 89 | 7 | M9321 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | GPC3 STK26 GRK5 LPL PAK3 PPP1R13B PLA2G4A CACNA1H G6PD ANGPTL1 OLFML3 FKBP5 EPHA7 | 2.06e-05 | 768 | 90 | 13 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | GPC3 STK26 GRK5 NTNG1 PAK3 PPP1R13B PLA2G4A CACNA1H DSCC1 G6PD OLFML3 FKBP5 EPHA7 | 2.88e-05 | 793 | 90 | 13 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 2.92e-05 | 373 | 90 | 9 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | GPR50 ABCA5 CAMK2D SCN1A SCN2A LPL SOCS4 NTNG1 LRP6 PLA2G4A OLFML3 CDC23 SULT1E1 | 4.02e-05 | 819 | 90 | 13 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 7.04e-05 | 418 | 90 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | GPC3 GRK5 SCN2A NTNG1 PAK3 PLA2G4A CACNA1H G6PD ANGPTL1 OLFML3 FKBP5 EPHA7 | 1.01e-04 | 773 | 90 | 12 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | GPC3 STK26 GRK5 NTNG1 PAK3 PPP1R13B PLA2G4A CACNA1H DSCC1 OLFML3 FKBP5 EPHA7 | 1.06e-04 | 777 | 90 | 12 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | BM Top 100 - thalamus | 1.40e-04 | 62 | 90 | 4 | BM Top 100 - thalamus | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 1.58e-04 | 364 | 90 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.63e-04 | 191 | 90 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | ALKBH8 GLA GPC3 STK26 GRK5 SCN2A LPL PPP1R13B PLA2G4A OLFML3 FKBP5 EPHA7 | 1.89e-04 | 827 | 90 | 12 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | GLA GPC3 STK26 GRK5 LPL PAK3 PPP1R13B PLA2G4A DSCC1 OLFML3 FKBP5 EPHA7 | 2.41e-04 | 849 | 90 | 12 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | BMPR2 STK26 DNAH2 NTNG1 LPGAT1 PLA2G4A ATP5MJ ANGPTL1 OLFML3 EPAS1 EPHA7 | 2.62e-04 | 731 | 90 | 11 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | GLA GPC3 ERN1 STK26 GRK5 LPL PLA2G4A KCNG3 DSCC1 OLFML3 FKBP5 EPHA7 | 2.65e-04 | 858 | 90 | 12 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | DOCK2 ERN1 STK26 GRK5 SCN2A CASP6 PLA2G4A KCNG3 OLFML3 FKBP5 EPHA7 | 2.91e-04 | 740 | 90 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_200 | 3.04e-04 | 138 | 90 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.04e-04 | 138 | 90 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_1000 | |
| CoexpressionAtlas | NK cells, NK.Sp, NK1.1+, Spleen, avg-3 | 3.46e-04 | 409 | 90 | 8 | GSM538315_500 | |
| CoexpressionAtlas | NK cells, NK.H+.MCMV7.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3 | 3.69e-04 | 413 | 90 | 8 | GSM538303_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | 4.19e-04 | 421 | 90 | 8 | gudmap_developingKidney_e15.5_Peripheral blastema_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.84e-04 | 234 | 90 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 4.89e-04 | 153 | 90 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-07 | 200 | 90 | 7 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | facs-Large_Intestine-Proximal|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 168 | 90 | 6 | 23e0e1592d7400012d289adb10c7598285bae2e9 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-06 | 168 | 90 | 6 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 1.23e-06 | 169 | 90 | 6 | 625788d86f0ceebcf2653a251db1f1a9f9746d29 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 173 | 90 | 6 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 173 | 90 | 6 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.58e-06 | 192 | 90 | 6 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 2.74e-06 | 194 | 90 | 6 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.91e-06 | 196 | 90 | 6 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.99e-06 | 197 | 90 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.99e-06 | 197 | 90 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.08e-06 | 198 | 90 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.08e-06 | 198 | 90 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.08e-06 | 198 | 90 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|Control_saline / Treatment groups by lineage, cell group, cell type | 3.17e-06 | 199 | 90 | 6 | e1240bfcdce76ec018599c50350748f9c7b8fb0e | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 146 | 90 | 5 | b76110b159acd27a2c8d6a9f98336608ace1ec12 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-05 | 147 | 90 | 5 | 1ecd7c084e73eb6fae1ab1f9aae17115d3d62cbd | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-05 | 155 | 90 | 5 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages-Mast-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-05 | 159 | 90 | 5 | 81782e9e370558d61af5e0c760ac9759d69fb725 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.95e-05 | 162 | 90 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 163 | 90 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 163 | 90 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.07e-05 | 164 | 90 | 5 | 81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 168 | 90 | 5 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 168 | 90 | 5 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.39e-05 | 169 | 90 | 5 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-05 | 177 | 90 | 5 | ac8f774596068e66c0a9ea8a318be0ce5f5df834 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-05 | 177 | 90 | 5 | d9c4a93b0e04a13bf39992dd1c1ec8df2c5f89fe | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 178 | 90 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-erythroid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.15e-05 | 179 | 90 | 5 | c17ae394b855f01f8ca1765c416fd8b34a96e60b | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 181 | 90 | 5 | a52e367f0909689174b3534f0cd51f36abe1b49f | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.35e-05 | 90 | 90 | 4 | 3817a5b0235e632d976ea565175bdbebbd959bf0 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.35e-05 | 90 | 90 | 4 | a528f5dcee1a356dea89ff2588d2e0f276f2d5fc | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.78e-05 | 186 | 90 | 5 | 18fd311252299d6d30ddb32002ed069056108206 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-05 | 187 | 90 | 5 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-05 | 187 | 90 | 5 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-05 | 192 | 90 | 5 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 192 | 90 | 5 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.40e-05 | 192 | 90 | 5 | 5995bae840c0b3f420288f557634d0ae9a12a6ae | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.62e-05 | 194 | 90 | 5 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.62e-05 | 194 | 90 | 5 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 4.62e-05 | 194 | 90 | 5 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | 21-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 4.62e-05 | 194 | 90 | 5 | 749dd8113ef260e00facac09de9861d61725124a | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 4.74e-05 | 195 | 90 | 5 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.74e-05 | 195 | 90 | 5 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 4.74e-05 | 195 | 90 | 5 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-05 | 196 | 90 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.85e-05 | 196 | 90 | 5 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.85e-05 | 196 | 90 | 5 | ee45e4de9d706ec87094e87f47d3e514539b8092 | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 4.85e-05 | 196 | 90 | 5 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.85e-05 | 196 | 90 | 5 | fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 4.97e-05 | 197 | 90 | 5 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.97e-05 | 197 | 90 | 5 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.97e-05 | 197 | 90 | 5 | d9e196c8b4a6ede4733946dbdba3331534954beb | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.09e-05 | 198 | 90 | 5 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.09e-05 | 198 | 90 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.09e-05 | 198 | 90 | 5 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | IPF|World / Disease state, Lineage and Cell class | 5.09e-05 | 198 | 90 | 5 | 7f8734729194caccab8ec98e6c1a00ff5c3655af | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.09e-05 | 198 | 90 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 5.09e-05 | 198 | 90 | 5 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | 15-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 5.09e-05 | 198 | 90 | 5 | e87d1fe2befbd32b0c723ab43b9de95495ea3ee3 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 5.22e-05 | 199 | 90 | 5 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-05 | 199 | 90 | 5 | 9846d6a31635fde759d55674631c11ab9270a603 | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 5.22e-05 | 199 | 90 | 5 | 95403988caef322314f4ed15415ad1a9a987adc1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.34e-05 | 200 | 90 | 5 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.34e-05 | 200 | 90 | 5 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3---L2-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | 9c89e91bb630cc306a820927a36ea6fb3d13e9d7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.34e-05 | 200 | 90 | 5 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | 15-Airway|15 / Age, Tissue, Lineage and Cell class | 5.34e-05 | 200 | 90 | 5 | ba4b8d5becf81351901c2ecac74ffa28e29586f3 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.34e-05 | 200 | 90 | 5 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.34e-05 | 200 | 90 | 5 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 90 | 5 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | 8821574d17b55dfea3ca0204e6b4c0ca6b19588a | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | 2200a621da1634728a49b1706e422e3e78b1f3bf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.34e-05 | 200 | 90 | 5 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | 96b1d2e70fbbba744fd4356a70efcf356aca9abc | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.34e-05 | 200 | 90 | 5 | 94bd00fb6ff0dcb668eb36ec2085f1c3128855b6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.34e-05 | 200 | 90 | 5 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 90 | 5 | ad6f1d4d7f5d7bab2ba2e4fff58c535290065c0e | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.60e-05 | 107 | 90 | 4 | 410b37beffaf637a2a64c9d0ce7baf81f4bc667c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.60e-05 | 107 | 90 | 4 | 5bae4b3aede9bcbf7e88414e3453973cc8b0c3e7 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.61e-05 | 111 | 90 | 4 | 1847dde68d349114286bc3317be6339666df4aa2 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.36e-04 | 129 | 90 | 4 | b3cb0c10659d1216b8f7de3aa1f9aac101cb65dd | |
| ToppCell | Severe-B_intermediate-14|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.97e-04 | 142 | 90 | 4 | f9cbc266fcea19bec504be4f3a28d1173c6b2e3c | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.02e-04 | 143 | 90 | 4 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-04 | 144 | 90 | 4 | 5e948d4cb913ccd8f82262a1b4d20967aadab3ab | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-04 | 149 | 90 | 4 | 59aa1f2a5cbeba64c4529fb05f544db17fd8b188 | |
| ToppCell | remission-multiplets|remission / disease stage, cell group and cell class | 2.37e-04 | 149 | 90 | 4 | e9974260a5f2999b363f306cae005698c912893a | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-04 | 149 | 90 | 4 | 1527cdd98a2734cbf8ce4c6170557280b71c55cb | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-04 | 150 | 90 | 4 | ccb782fbcb3122266354a112a9a850506664f44d | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-04 | 150 | 90 | 4 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-04 | 151 | 90 | 4 | b85a763459a0f019d1f9975d09b9f2247d62c9d3 | |
| ToppCell | COVID-19_Mild-PLT_0|World / Disease Group and Platelet Clusters | 2.55e-04 | 152 | 90 | 4 | d49f7c0681500fc4d93818d47e8e8afb726c23d9 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-04 | 154 | 90 | 4 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-04 | 154 | 90 | 4 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.75e-04 | 155 | 90 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-04 | 156 | 90 | 4 | 8349604bd801e20d33770f7d8243598c3756302b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-04 | 157 | 90 | 4 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.96e-04 | 158 | 90 | 4 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| Drug | hydroxyl radicals | TYR DOCK5 ABCC1 EFL1 PTPA EPM2A GLA CYP4A11 LPL ENTPD3 PPP1R13B LRP6 PLA2G4A CHIT1 G6PD ENOPH1 F9 CDC23 CYP4A22 | 9.85e-07 | 1341 | 90 | 19 | CID000000961 |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.20e-06 | 198 | 90 | 8 | 7357_UP | |
| Drug | 3,5-di-tert-butylcatechol | 1.30e-06 | 21 | 90 | 4 | CID000066099 | |
| Drug | NSC618487 | STK10 PTPA EPHA6 ERN1 CAMK2D LPL PAK5 ENTPD3 PAK3 CASP6 PLA2G4A GRIN2C PAK6 VDAC1 EPHA7 | 3.57e-06 | 933 | 90 | 15 | CID000005279 |
| Drug | gb1a | 4.93e-06 | 9 | 90 | 3 | CID000467746 | |
| Drug | sunitinib | 1.30e-05 | 130 | 90 | 6 | CID005329102 | |
| Drug | 2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol | 1.55e-05 | 2 | 90 | 2 | ctd:C438607 | |
| Drug | Baclofen | 1.55e-05 | 2 | 90 | 2 | DB00181 | |
| Drug | CGP 71872 | 1.55e-05 | 2 | 90 | 2 | ctd:C104980 | |
| Drug | CGP 55845A | 1.55e-05 | 2 | 90 | 2 | ctd:C085075 | |
| Drug | 3-aminopropylphosphinic acid | 1.55e-05 | 2 | 90 | 2 | ctd:C061388 | |
| Drug | NSC227243 | 2.11e-05 | 14 | 90 | 3 | CID000024346 | |
| Drug | Zonisamide | 3.90e-05 | 17 | 90 | 3 | DB00909 | |
| Drug | vandetanib | 4.61e-05 | 99 | 90 | 5 | CID003081361 | |
| Drug | GW 7845 | 4.67e-05 | 18 | 90 | 3 | ctd:C401311 | |
| Disease | Bipolar Disorder | 1.42e-05 | 477 | 89 | 9 | C0005586 | |
| Disease | Nonorganic psychosis | 5.76e-05 | 69 | 89 | 4 | C0349204 | |
| Disease | level of lipoprotein lipase in blood serum | 8.94e-05 | 5 | 89 | 2 | OBA_2042223 | |
| Disease | Cerebral Small Vessel Diseases | 8.94e-05 | 5 | 89 | 2 | C2733158 | |
| Disease | Rett Syndrome, Atypical | 8.94e-05 | 5 | 89 | 2 | C2748910 | |
| Disease | atopy | 8.94e-05 | 5 | 89 | 2 | EFO_0002686 | |
| Disease | Epilepsy, Cryptogenic | 1.13e-04 | 82 | 89 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 1.13e-04 | 82 | 89 | 4 | C0751111 | |
| Disease | Aura | 1.13e-04 | 82 | 89 | 4 | C0236018 | |
| Disease | congenital disorder of glycosylation (implicated_via_orthology) | 1.34e-04 | 6 | 89 | 2 | DOID:5212 (implicated_via_orthology) | |
| Disease | Epilepsy, Generalized | 1.34e-04 | 6 | 89 | 2 | C0014548 | |
| Disease | X-14939 measurement | 1.34e-04 | 6 | 89 | 2 | EFO_0800747 | |
| Disease | Seizure, Febrile, Simple | 1.87e-04 | 7 | 89 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 1.87e-04 | 7 | 89 | 2 | C0751057 | |
| Disease | disease recurrence, response to allogeneic hematopoietic stem cell transplant, donor genotype effect measurement | 1.87e-04 | 7 | 89 | 2 | EFO_0004952, EFO_0007044, EFO_0007892 | |
| Disease | Psychotic Disorders | 2.53e-04 | 101 | 89 | 4 | C0033975 | |
| Disease | Febrile Convulsions | 3.19e-04 | 9 | 89 | 2 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 3.19e-04 | 9 | 89 | 2 | C3502809 | |
| Disease | Schizophrenia | TYR CACNA1F GPR50 LPL NTNG1 PLA2G4A GRIN2C LARS2 GABBR1 NPAS1 | 3.29e-04 | 883 | 89 | 10 | C0036341 |
| Disease | Epilepsy | 3.38e-04 | 109 | 89 | 4 | C0014544 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.98e-04 | 10 | 89 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.98e-04 | 10 | 89 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | myelodysplastic syndrome | 3.98e-04 | 10 | 89 | 2 | EFO_0000198 | |
| Disease | Pulmonary arterial hypertension | 3.98e-04 | 10 | 89 | 2 | C2973725 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 4.86e-04 | 11 | 89 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.82e-04 | 12 | 89 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Metastatic melanoma | 5.89e-04 | 54 | 89 | 3 | C0278883 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 6.87e-04 | 13 | 89 | 2 | C0751122 | |
| Disease | MMR-related febrile seizures | 9.21e-04 | 15 | 89 | 2 | EFO_0006519 | |
| Disease | P wave duration | 9.21e-04 | 15 | 89 | 2 | EFO_0005094 | |
| Disease | Idiopathic pulmonary arterial hypertension | 1.05e-03 | 16 | 89 | 2 | C3203102 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 1.05e-03 | 16 | 89 | 2 | C0393706 | |
| Disease | succinylcarnitine measurement | 1.05e-03 | 16 | 89 | 2 | EFO_0020020 | |
| Disease | sphingomyelin 14:0 measurement | 1.19e-03 | 17 | 89 | 2 | EFO_0010390 | |
| Disease | diet measurement | TYR PTPA ANKUB1 SCN2A KCNK5 CACNA1H ATP5MJ LARS2 DNAH5 EPHA7 | 1.24e-03 | 1049 | 89 | 10 | EFO_0008111 |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.33e-03 | 18 | 89 | 2 | HP_0002373 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 1.49e-03 | 19 | 89 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.52e-03 | 163 | 89 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | coagulation factor V measurement | 1.65e-03 | 20 | 89 | 2 | EFO_0008087 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.00e-03 | 22 | 89 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Drug toxicity | 2.12e-03 | 84 | 89 | 3 | C0013221 | |
| Disease | Adverse reaction to drug | 2.12e-03 | 84 | 89 | 3 | C0041755 | |
| Disease | Involutional paraphrenia | 2.58e-03 | 25 | 89 | 2 | C1571983 | |
| Disease | Psychosis, Involutional | 2.58e-03 | 25 | 89 | 2 | C1571984 | |
| Disease | Involutional Depression | 2.58e-03 | 25 | 89 | 2 | C0011574 | |
| Disease | triacylglycerol 56:5 measurement | 2.79e-03 | 26 | 89 | 2 | EFO_0010432 | |
| Disease | Glycogen Storage Disease | 3.01e-03 | 27 | 89 | 2 | C0017919 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IIGKSYDYGIDMWSV | 861 | Q13523 | |
| ALVLGYEGWLAGYQM | 141 | P21796 | |
| KSKWGIGYRLSMYID | 701 | Q8WWZ7 | |
| QYRMLAKHGGYVWLE | 306 | Q99814 | |
| AWYGLGQTYEILKMP | 401 | Q9UJX2 | |
| YWRAYAVGDVEKMAL | 456 | Q9UJX2 | |
| KLVIDWHNYGYSIMG | 151 | Q9BT22 | |
| GGKALIYVWAMEQEY | 496 | Q96BT7 | |
| YTEIDWKAYMAEVEG | 66 | Q92685 | |
| EVLMKTLWGDYYINM | 261 | Q7Z2Z2 | |
| AIIWKYGGIYMDTDV | 156 | Q9UNA3 | |
| WGGKVRVQLYDPDYM | 91 | Q02928 | |
| MVSEGWKDAGYEYLC | 76 | P06280 | |
| YCVMLGYWGEPQKTE | 466 | Q96CM8 | |
| DGEYWLGLENIYMLS | 346 | O95841 | |
| LGVMNKGVAYALWDY | 1016 | Q96KQ4 | |
| IMNKGVIYALWDYEP | 1056 | Q13625 | |
| EEGVYGWITANYLMG | 181 | O75355 | |
| MKRVGFQYEGTYKWV | 496 | P11413 | |
| AWDDGYQIVYKLEMR | 386 | Q9NRN5 | |
| DLLDKGQVMTGYYRW | 356 | Q99742 | |
| IEGEWNGVMYAKYAT | 621 | Q96SU4 | |
| NEMIYWGLEGAHLEY | 96 | Q8TAE7 | |
| KEGGMLAYYEVCSWK | 296 | Q13231 | |
| VVDMYSSYLVGDELW | 506 | Q9P286 | |
| EDWNVVMYDGIMAYG | 711 | O60840 | |
| YGKIVSWLEMEYGLS | 291 | Q13451 | |
| SYLVGDELWVVMEYL | 346 | O75914 | |
| LAVWLSMIGLAQYYK | 546 | Q8WXD9 | |
| YFALMDGKVYDITEW | 586 | Q6Y2X3 | |
| EMYKSYLVGEELWVL | 466 | Q9NQU5 | |
| TMIKLYREEGLAYIW | 216 | O95278 | |
| YIEGIMYKWLLGMVA | 56 | Q92604 | |
| MAGVVEIDKYWREYI | 286 | P51654 | |
| MNTWLGIFYGYKGLL | 766 | Q9UBS5 | |
| EMAGKIPNWLYLAAY | 266 | Q13585 | |
| SWYIQDLCEMLGKYG | 226 | P55212 | |
| SYGIVMWEVMSYGER | 811 | P29323 | |
| VFMVTEGWNYIEGLY | 181 | O95279 | |
| GMYESWVPKLVAALY | 86 | P06858 | |
| WGEECAMKGKYGIYT | 431 | P00740 | |
| YMTAKYGDELAWSEV | 1371 | O94915 | |
| YPEGMAVDWLGKNLY | 706 | O75581 | |
| GNILALWVFYGYMKE | 36 | Q9BXC1 | |
| SYGIVMWEVMSYGER | 821 | Q15375 | |
| EMACVYKGGYWEAKE | 891 | Q969R2 | |
| KWREAGMKVYIYSSG | 141 | Q9UHY7 | |
| YDTYVGSGWLIKGMD | 201 | Q96AY3 | |
| IGGYWRILEFDYEMK | 191 | Q9BVC3 | |
| YETIIGYFDKGKMWE | 1281 | Q92608 | |
| IGDTVHILEMYEGWY | 31 | Q9H7D0 | |
| LYMGKKQDIWYVIDL | 116 | O75460 | |
| WGGKVRVQLYDPDYM | 91 | Q5TCH4 | |
| AGYDYKVMIWNLDTK | 151 | Q92828 | |
| LKQVDMYALGLIYWE | 401 | Q13873 | |
| DNSGLYAKWLVEYVM | 1016 | Q6IQ26 | |
| THMTIWLGIVYAYKG | 651 | O75899 | |
| WLGIVYAYKGLLMLF | 656 | O75899 | |
| EQPGVYTKVAEYMDW | 606 | P03952 | |
| YYTKVYQEIWIGMGL | 16 | P56378 | |
| LMEWLKSTDYGKYEG | 391 | Q9NV70 | |
| PDYWGLGCLIYEMIE | 366 | P34947 | |
| TLEGWVDIMYYVMDA | 376 | O95180 | |
| RCGMVYTDYADLGWK | 2221 | Q9P225 | |
| YGLYLEGAGWDKRNM | 4536 | Q8TE73 | |
| YGKPVDMWACGVILY | 191 | Q13557 | |
| YIEAAYKVADYGMWE | 171 | P46019 | |
| WVEFSPYEIGMAKYG | 346 | P47712 | |
| SYGIVMWEVMSYGER | 861 | Q9UF33 | |
| GQVKLSVYWDYMKAI | 956 | P33527 | |
| QIYTEEGKVWDYMAC | 36 | Q9Y2I2 | |
| YMEKEGLYEKVVTEW | 631 | P0C091 | |
| LVPIQLWYKYIMGDD | 311 | Q96EX2 | |
| AVADYWMPVDLYIGG | 546 | Q15031 | |
| RAGEWKLGGLDYMYS | 151 | Q96KG9 | |
| YGSYLKGSKLWIIME | 86 | Q9P289 | |
| YIYGLWMKKTFGVNE | 376 | Q6P1X5 | |
| CYWGVMDKYAAEALL | 286 | Q8WXH5 | |
| KGYYEWALLVAVEMG | 966 | Q8TE82 | |
| YIFILEMLLKWVAYG | 1261 | P35498 | |
| LVVGMLIKAERYYAW | 381 | A6NHY2 | |
| YLELMYAGAALKDSW | 46 | A6NFN9 | |
| YWIVAGKALDYEQML | 781 | Q96JG6 | |
| TWVSEIVYMIYKEGD | 51 | P49888 | |
| MGKWKRSQAYADYIG | 36 | Q15257 | |
| LLGAYYHDGKLWIMI | 96 | O94804 | |
| YIFILEMLLKWVAYG | 1251 | Q99250 | |
| YYVSMDALLGGSEIW | 181 | P14679 | |
| ELYWDAMLEKYGTVV | 221 | Q9NWS9 | |
| VFVLEYYLDTLWKGM | 51 | Q2WGJ8 | |
| LLWYFLGYKAEVMVS | 71 | Q8IU80 | |
| EVDGWTLRMLIDYVY | 101 | O95198 | |
| WNGMIGEVYYKRADM | 491 | Q14957 |